Summary: For many people it not feasible to call doctor every time or call the nurse for the intra-mascular infection. Read this article, which is penned for you and help you know the process of intramascular self-injection.
With adequate care and technique, you may safely administer intramuscular self injection at home. This pamphlet will walk you through the processes of injecting yourself. Please consult a doctor if you have any questions or concerns.
Outlined below are the supplies:
- Syringes and needles
- The medication solution is in a vial
- Gauze or alcohol swabs
- Band-Aids
- Container for Sharps
Outlined below are a few steps involved that can help you get the intramascular injection.
- Hands should be washed thoroughly with soap and water. Gather your materials and lay them out on a clean, dry surface. Steps 2–7 can be skipped if your syringe is already drawn up.
- Unless your syringe already has a needle connected, screw a needle onto the syringe hub.
- Remove the plastic lid from the vial. Wipe the affected area with an alcohol swab in an outward circular motion.
- Remove the plastic lid from the vial. Wipe the area with an alcohol swab in an outer circular motion for 10 seconds.
- Remove the needle cover from the needle. Pull the plunger back to the desired volume to draw air into the syringe.
- There are Needle free injection devices also available. Through the rubber lid, insert the needle straight into the vial. Push down on the plunger to inject air into the bottle.
- Air bubbles in the syringe are a red flag. By flicking the syringe with your finger, you may remove bubbles. If there is an air bubble at the top of the syringe, gently press down on the plunger to return the air to the bottle.
- Unless your medical practitioner tells you otherwise, clean the skin area with an alcohol swab. Clean a 2-inch-diameter circle. Moving outward from the injection site, make strong circular motions. Allow 20 seconds for the area to dry.
- Remove the needle cover from the needle. Never put your hand near the needle.
- If you're right-handed, use your left hand to spread the skin at the spot between your thumb and index finger; if you're left-handed, use your right hand.
Are you looking for medical at-home services or consultation? If so then you need to do a little leg work and find the best service provider.
The global needle free injection market size is expected to touch USD 25,057.4 million by 2023 owing to a high prevalence of diabetes and chronic diseases.
Market Research Future’s (MRFR) latest study reveals that the market is predicted a 15.28 % CAGR during the forecast period (2018–2023).
Needle free injections are medical devices which deliver drugs directly via the skin instead of using hypodermic needles as a medium.
By product type, the market has been segmented into fillable and prefilled needle free injectors.
Technologies covered in the report include laser-powered, jet-based, and spring-based.
Among these, the jet-based segment can touch a size of USD 10,391.3 million by 2023 owing to a faster method of delivery as compared to other technologies.
Players, stakeholders, and other participants in the global Self-Injection Devices market will be able to gain the upper hand as they use the report as a powerful resource.
The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.Download FREE Sample of this Report @ https://www.statsmarketresearch.com/download-free-sample/6522042/global-china-selfinjection-devices-2027-701For China market, this report focuses on the Self-Injection Devices market size by players, by Type, and by Application, for the period 2016-2027.
The key players include the global and local players which play important roles in China.Segment by TypeNeedle-Free InjectorsPen InjectorsWearable InjectorsSegment by ApplicationPatientPhysiciansHome Care SettingsOthersBy RegionNorth AmericaU.S.CanadaEuropeGermanyFranceU.K.ItalyRussiaAsia-PacificChinaJapanSouth KoreaIndiaAustraliaChina TaiwanIndonesiaThailandMalaysiaLatin AmericaMexicoBrazilArgentinaMiddle East & AfricaTurkeySaudi ArabiaUAEBy CompanyAntares PharmaPfizer Inc.Penjet Corporation3M CompanyAbbvie, Inc.PharmaJetBaxter International Inc.Becton Dickinson & CompanyTerumo CorporationReasons to Purchase Our Research Report:1.
Market dynamics scenario, along with growth opportunities of the market in the years to come3.
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects4.
Regional and country-level analysis integrating the demand and supply forces that are influencing the growth of the market.5.
Major factors driving the growth of this market include growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices.Key Factors Driving Market Growth:The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period.Revenue Growth Analysis:Growth in this market is mainly driven by growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices.
The report segments the market based on product, technology, type, site of delivery, applications, end user and regions.
Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors and vibration-based needle-free injectors.
The jet-based needle-free injectors are expected to witness the highest growth during the forecast period, due to their advantages over the other injector systems.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors and vibration-based needle-free injectors.
The jet-based needle-free injector is expected to account for the largest market share in 2016, due to their advantages over the other injector systems.Based on the Applications, the market is segmented into vaccine delivery, insulin delivery, Oncology, pain management and other applications; the vaccine delivery application segment is projected to be the fastest-growing segment during forecast period in 2016.
The growth of this market primarily attributed to factors such as the rising incidence of chronic diseases, technological advancement, and growing preference for self-medication.Based on the end user, the market is segmented into Hospitals and Clinics, home care settings, research laboratories, pharmaceutical and biotechnological companies and other end user.
Major factors driving the growth of this market include growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices.
On the other hand, high development cost of needle-free injection system over the conventional needle injection may hinder the growth of this market during the forecast period.
The report segments the market based on product, technology, type, site of delivery, applications, end user and regions.The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period.Growth in this market is mainly driven by growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices.
On the other hand, high development cost of needle-free injection systems over the conventional needle injection may hinder the growth of this market during the forecast period.Market DynamicsGrowing Prevalence of Chronic DiseasesIncreasing Incidence of Communicable Diseases Due to Needlestick InjuriesRise in Demand for Self-Injection DevicesBased on the Applications, the market is segmented into vaccine delivery, insulin delivery, Oncology, pain management and other applications; the vaccine delivery application segment is projected to be the fastest-growing segment during forecast period in 2016.
The growth of this market primarily attributed to factors such as the rising incidence of chronic diseases, technological advancement, and growing preference for self-medication.Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors and vibration-based needle-free injectors.
The jet-based needle-free injector is expected to account for the largest market share in 2016, due to their advantages over the other injector systems.The geographical regions mapped in the report are:1.
Global Needle Free Injection Market Research Report information: Product (Fillable) Technology (Jet-Based) Usability (Reusable), Type of Medication (Liquid-Based), Site of Delivery (Intra dermal), Application (Vaccination) End Users (Hospitals) – Forecast Till 2023Market Highlights:The global needle free injection market size is expected to touch USD 25,057.4 million by 2023 owing to high prevalence of diabetes and chronic diseases.
Needle free injections are medical devices which deliver drugs directly via the skin instead of using hypodermic needles as a medium.
In addition, rising investments in biopharmaceuticals are expected to provide the market a much-needed impetus.Awareness among patients regarding benefits of needle free injections is anticipated to prevent reuse of needles and reduce the probability of contamination.
Technologies covered in the report include laser-powered, jet-based, and spring-based.
The liquid-based segment held a large share of the market in 2017.
The insulin delivery segment is projected to expand at a 14.9% CAGR over the forecast period fueled by large pool of diabetics demanding a pain-free solution for receiving insulin.
